MMP1 and cancer: Interestingly, the caspase activities in HPMCs treated with the patient-derived EVs with high amounts of MMP1 mRNA (cancer 1 and cancer 2) were significantly increased and the morphology of the HPMCs was altered in a similar manner to the ES-2 EV treatment (Fig. 6f).